Cancer care treatment attrition in adults: Measurement approaches and inequities in patient dropout rates–a rapid review
J Shand, E Stovold, L Goulding, K Cheema - BMC cancer, 2024 - Springer
Background Cancer treatment attrition refers to the discontinuation of prescribed cancer
therapies before completion. It can significantly impact patient outcomes and cancer survival …
therapies before completion. It can significantly impact patient outcomes and cancer survival …
Fruquintinib as new treatment option in metastatic colorectal cancer patients: is there an optimal sequence?
E Stucchi, M Bartolini, M Airoldi, R Fazio… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Available treatments for colorectal cancer are limited. However, in the last few
years several advances and new treatment options became available and expanded the …
years several advances and new treatment options became available and expanded the …
[HTML][HTML] Real-World Treatment Patterns, Health Outcomes, and Healthcare Resource Use in Advanced Common EGFR-Positive Non-Small Cell Lung Cancer Patients …
WY Cheung, C Carbonell, V Navani, RS Sangha… - Current …, 2024 - mdpi.com
There is limited information on the treatment trajectory and outcomes of patients with
advanced cEGFRm NSCLC treated with osimertinib in routine clinical practice in Canada …
advanced cEGFRm NSCLC treated with osimertinib in routine clinical practice in Canada …